NASDAQ:EDIT

Editas Medicine Stock Forecast

etoro logo Buy EDIT
*Your capital is at risk
$2.44
-0.0400 (-1.61%)
At Close: Jun 11, 2026
AI Analysis AI Analysis of EDIT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add EDIT to Watchlist?
Some Reasons Why To Add EDIT:
  • High gross margin of 98.8%
  • Healthy interest coverage ratio of 100.6x
  • Highly efficient cash conversion (100% FCF/OCF ratio)
PDF

Editas Medicine, Inc stock price down 1.61% on Thursday
(Updated on Jun 11, 2026)

Sell candidate since Jun 09, 2026 Loss -7.92%

The Editas Medicine, Inc stock price fell by -1.61% on the last day (Thursday, 11th Jun 2026) from $2.48 to $2.44. During the last trading day the stock fluctuated 6.09% from a day low at $2.38 to a day high of $2.53. The price has fallen in 7 of the last 10 days and is down by -28.86% for this period. Volume has increased on the last day by 683 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $5.23 million.

The stock has broken the very wide and strong rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $2.57. A reaction back to this level may hold a second chance to get out before further falls.

EDIT Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Editas Medicine, Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.67 and $2.91. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 27, 2026, and so far it has fallen -31.65%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation A sell signal from a double top formation was found on Wednesday, May 27, 2026 with a target of $2.72. Despite whether the objective of the signal formation has been reached the stock may continue to fall.

Support, Risk & Stop-loss for Editas Medicine, Inc stock

Editas Medicine, Inc finds support from accumulated volume at $2.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.145 between high and low, or 6.09%. For the last week, the stock has had daily average volatility of 9.02%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EDIT) For The Upcoming Trading Day Of Friday 12th

For the upcoming trading day on Friday, 12th we expect Editas Medicine, Inc to open at $2.45, and during the day (based on 14 day Average True Range), to move between $2.30 and $2.58, which gives a possible trading interval of +/-$0.280 (+/-12.18%) up or down from last closing price. If Editas Medicine, Inc takes out the full calculated possible swing range there will be an estimated 12.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.35 (3.69%) than the resistance at $2.78 (13.93%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Editas Medicine, Inc stock A Buy?

The Editas Medicine, Inc stock holds several negative signals and despite the positive trend, we believe Editas Medicine, Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.908 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 12, 2026 - $2.45 ( 0.342%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

EDIT Performance

Trading levels for EDIT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.59 6.28%
R2 2.54 4.01%
R1 2.50 2.61%
Price 2.44
S1 2.39 -1.93%
S2 2.36 -3.33%
S3 2.30 -5.60%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.89 18.44%
R2 2.82 15.57%
R1 2.78 13.93%
Price 2.44
S1 2.35 -3.69%
S2 2.32 -4.92%
S3 2.23 -8.61%

FAQ

What is the symbol for Editas Medicine, Inc Stock and on which exchange is it traded?
The symbol for Editas Medicine, Inc is EDIT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Editas Medicine, Inc Stock?
The Editas Medicine, Inc stock holds several negative signals and despite the positive trend, we believe Editas Medicine, Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Editas Medicine, Inc Stock?
Editas Medicine, Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Editas Medicine, Inc Stock.

What's the current price of Editas Medicine, Inc Stock?
As of the end of day on the Jun 11, 2026, the price of an Editas Medicine, Inc (EDIT) share was $2.44.

What is the 52-week high and low for Editas Medicine, Inc Stock?
The 52-week high for Editas Medicine, Inc Stock is $4.54 and the 52-week low is $1.66.

What is the market capitalization of Editas Medicine, Inc Stock?
As of the Jun 11, 2026, the market capitalization of Editas Medicine, Inc is 238.877M.

When is the next earnings date for Editas Medicine, Inc?
The upcoming earnings date for Editas Medicine, Inc is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT EDITAS MEDICINE, INC
Editas Medicine
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads to inherited childhood blindness. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, whic...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.01% Jun 05
TPR
$140.47
3.50% Jun 04
GLBE
$31.61
5.09% May 05
FIZZ
$34.11
8.36% May 01
W
WCLD
$27.34
12.18% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE